Symbols

VCEL

Vericel·NASDAQ

--(--)

VCEL Profile

Vericel Corporation

A leader in advanced therapies for the sports medicine and severe burn care markets

Industry

Biological Technology

Established Date

Listing Date

02/04/1997

Exchange

NASDAQ Stock Exchange

Full-time Employees

398

Fiscal Year Ends

12-31

Website

www.vcel.com

Security Type

Common stock

Office address

64 Sidney Street, Cambridge, MA 02139

Business

Introduction

Vericel Corporation was incorporated in Michigan in March 1989 and began employee operations in 1991. The Company is a fully integrated commercial-stage biopharmaceutical company and a leading provider of advanced therapies for the sports medicine and severe burn care markets. It sells three FDA-approved products in the US: MACI for cartilage repair, Epicel for severe burns, and NexoBrid for thermal burn eschar removal.